Literature DB >> 11010826

What does tuberculin reactivity after bacille Calmette-Guérin vaccination tell us?

D Menzies1.   

Abstract

The effect of bacille Calmette-Guérin (BCG) vaccination on tuberculin reactivity is briefly reviewed. BCG vaccination will almost invariably result in tuberculin conversion with a positive tuberculin skin test developing 4-8 weeks after vaccination. However, these tuberculin reactions will wane-rapidly in all individuals who receive the vaccine in the neonatal period and more slowly in those who are vaccinated at an older age such as during the primary-school years. Of BCG vaccine recipients whose initial tuberculin skin test is negative, 10%-25% will have a positive tuberculin skin test if they are retested within 1-4 weeks-the so-called "booster phenomenon. " There is no relationship between tuberculin reactivity after BCG vaccination and the protective efficacy of the vaccine against development of active tuberculosis. Therefore, the ideal BCG vaccine would produce a scar at the site of injection to identify individuals who have been vaccinated but would have no effect on tuberculin reactivity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11010826     DOI: 10.1086/314075

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  55 in total

1.  Tuberculin sensitivity among children vaccinated with BCG under universal immunization programme.

Authors:  V K Chadha; P S Jaganath; P Kumar
Journal:  Indian J Pediatr       Date:  2004-12       Impact factor: 1.967

2.  Evaluation of Treatment Indications, Tuberculin Skin Test, and Bacillus Calmette-Guerin Vaccination Scars in the Cases of Latent Tuberculosis Infection Treatment.

Authors:  Beyhan Çakar
Journal:  Turk Thorac J       Date:  2017-09-27

3.  Diagnostic value of interferon- gamma release assays (QuantiFERON-TB Gold® In Tube) in childhood tuberculosis.

Authors:  Rajeshwar Dayal; Vikas Verma; B Sharma; G Kumar; N Kumar; R Gupta; V M Katoch; Beenu Joshi; D S Chauhan
Journal:  Indian J Pediatr       Date:  2011-06-25       Impact factor: 1.967

4.  Childhood tuberculosis: In Canada and around the world.

Authors:  Anne Fanning
Journal:  Paediatr Child Health       Date:  2003-03       Impact factor: 2.253

5.  A clinical approach to paediatric tuberculosis in Canada.

Authors:  Ian Kitai; Patricia Malloy
Journal:  Paediatr Child Health       Date:  2003-03       Impact factor: 2.253

6.  Risk of latent TB infection in individuals employed in the healthcare sector in Germany: a multicentre prevalence study.

Authors:  Anja Schablon; Melanie Harling; Roland Diel; Albert Nienhaus
Journal:  BMC Infect Dis       Date:  2010-04-30       Impact factor: 3.090

7.  Clinico-epidemiological profile and diagnostic procedures of pediatric tuberculosis in a tertiary care hospital of western Nepal-a case-series analysis.

Authors:  Chandrashekhar T Sreeramareddy; Narayan Ramakrishnareddy; Ravi K Shah; Ramkaji Baniya; Pradipta K Swain
Journal:  BMC Pediatr       Date:  2010-08-09       Impact factor: 2.125

8.  Prevalence of latent tuberculosis infection among health care workers in a hospital for pulmonary diseases.

Authors:  Anja Schablon; Gudrun Beckmann; Melanie Harling; Roland Diel; Albert Nienhaus
Journal:  J Occup Med Toxicol       Date:  2009-01-09       Impact factor: 2.646

9.  Evaluation of the tuberculin skin test and the interferon-gamma release assay for TB screening in French healthcare workers.

Authors:  Dominique Tripodi; Benedicte Brunet-Courtois; Virginie Nael; Marie Audrain; Edmond Chailleux; Patrick Germaud; Frederique Naudin; Jean-Yves Muller; Martine Bourrut-Lacouture; Marie-Henriette Durand-Perdriel; Claire Gordeeff; Guyonne Guillaumin; Marietherese Houdebine; Francois Raffi; David Boutoille; Charlotte Biron; Gilles Potel; Claude Roedlich; Christian Geraut; Anja Schablon; Albert Nienhaus
Journal:  J Occup Med Toxicol       Date:  2009-11-30       Impact factor: 2.646

10.  Two loci control tuberculin skin test reactivity in an area hyperendemic for tuberculosis.

Authors:  Aurelie Cobat; Caroline J Gallant; Leah Simkin; Gillian F Black; Kim Stanley; Jane Hughes; T Mark Doherty; Willem A Hanekom; Brian Eley; Jean-Philippe Jaïs; Anne Boland-Auge; Paul van Helden; Jean-Laurent Casanova; Laurent Abel; Eileen G Hoal; Erwin Schurr; Alexandre Alcaïs
Journal:  J Exp Med       Date:  2009-11-09       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.